09 January 2002
Use of secretin in the treatment of childhood autism.Mariusz Czaja, Ewa Kozielska, Barbara Kamińska, Elzbieta Mazur, Maria Korzon
Med Sci Monit 2002; 8(1): RA22-26 :: ID: 420975
The paper presents current views concerning childhood autism. The authorspresent the concepts of etiology of this disorder, emphasizing the role of negative psychical stimuliin early childhood and the role of mother's contact with the child. Organic factors, including geneticbackground, developmental abnormalities of the nervous system, teratogenic factors and perinatal traumasare also taken into consideration. The role of metabolic factors and enterohormones, particularly thosebelonging to the secretin group and their effect on the function of the gastrointestinal tract and centralnervous system is emphasized. We discuss signs which may be indicative of first symptoms of autism indifferent age groups. A typical symptom of autism is no development of speech, observed from infancy,taking the form of complete mutism at later stages. It has been emphasized that most pathologic symptomsresult from altered perception of external stimuli, which arouse fear and anxiety. Autistic patientsmay suffer from gastrointestinal tract disturbances such as abdominal pains and diarrhea. Methods usedhitherto in the therapy of childhood autism, mainly by psychologists and psychiatrists, as well as someattempts of pharmacological treatment, are presented. The structure and function of secretin, as wellas its effects on the motor and secretory function of the stomach and the exocrine function of the pancreasare discussed. The role of secretin in diagnostic tests, among others in the diagnosis of gastrinoma,is emphasized. We also present the history of the application of secretin in the therapy of childhoodautism.
Keywords: Autistic Disorder, Child, Child, Preschool, Gastrointestinal Diseases, Secretin
01 May 2023 : EditorialEditorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor Therapy
Med Sci Monit 2023; 29:e940911
31 May 2023 : Review articlePrevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A Review
Med Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical ResearchA Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...
Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review articleA Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...
Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database AnalysisThe COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland
Med Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952